Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Fenofibrate Stories

2014-04-11 12:00:31

Atrasentan reduces blood pressure, cholesterol, and urinary protein excretion A drug called atrasentan provides health benefits for patients who have both diabetes and kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings suggest that atrasentan may help maintain the well-being of many patients who are at high risk of experiencing serious medical problems. Individuals with type 2 diabetes have a high...

2014-03-27 04:20:44

Companies to Host Investor Conference Call on Alirocumab on March 31 at 9 AM EDT PARIS and TARRYTOWN, N.Y., March 27, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from alirocumab clinical studies will be presented at the American College of Cardiology's (ACC) 63rd Annual Scientific Session in Washington, D.C. March 29-31. Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein...

2014-02-05 11:24:51

An educational toolkit designed to improve care of patients with diabetes was not effective, Baiju R Shah and colleagues (University of Toronto) found in a cluster randomized trial conducted in 2009-2011. During 10 months of follow-up, patients of Canadian family physicians who had been cluster-randomized to receive the toolkit did not receive improved care and their outcomes did not differ compared with patients of physicians who did not receive the toolkit. All 933,789 people aged ≥40...

2014-02-04 11:23:37

Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus, according to a study by Jeff D. Williamson, M.D., M.H.S., of the Wake Forest School of Medicine, Winston-Salem, N.C., and colleagues. Patients with type 2 diabetes (T2DM) are at increased risk for decline in cognitive function, for reduced brain volume and increased white matter lesions on brain imaging,...

2013-10-22 12:29:10

MUMBAI, India and BALTIMORE, October 22, 2013 /PRNewswire/ -- Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its supplemental New Drug Application (sNDA) for Antara(R) (Fenofibrate) capsules, 30 mg & 90 mg strengths from the United States Food and Drug Administration (FDA). Lupin Pharmaceuticals Inc. (LPI), the company's US subsidiary, will commence marketing the product shortly. LPI currently markets and promotes Antara(R)...

2013-09-02 09:48:05

Dr Nakano said: "Many randomized clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels." The current study used the Ibaraki Cardiovascular Assessment Study (ICAS), a registry of 2,238 patients from 12...

2013-07-18 12:28:01

WOODCLIFF LAKE, N.J., July 18, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for fenofibric acid EQ 45 mg and EQ 135 mg delayed-release (DR) capsules. Fenofibric acid DR is the generic version of AbbVie's Trilipix(®) and is indicated: in combination with a statin to reduce TG and increase HDL-C in patients with mixed dyslipidemia and CHD...

2013-07-15 12:25:18

PITTSBURGH, July 15, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Fenofibric Acid Delayed-release Capsules, 45 mg and 135 mg. Fenofibric Acid Delayed-release Capsules, 45 mg and 135 mg, are the generic version of Abbott's Trilipix® Capsules, which are indicated as an adjunct to diet in combination with a statin to reduce triglyceride and increase high-density lipoprotein cholesterol in...

Study Says Statins Are Safe
2013-07-10 13:49:13

Brett Smith for redOrbit.com - Your Universe Online A comprehensive study review has added to the growing body of evidence indicating the anti-inflammatory drugs known as statins have no significant side effects. The case for statin use is already strong, and some doctors are calling for its widespread use as a preventative regimen. Oxford University epidemiologist Rory Collins caused a stir last year with his presentation entitled, "The Case for Statins in a Wider Population" to the...

2013-05-24 13:52:41

But some statins can reduce risk of diabetes Treatment with high potency statins (especially atorvastatin and simvastatin) may increase the risk of developing diabetes, suggests a paper published today on bmj.com. Statins are among the most widely prescribed medications for the prevention of cardiovascular events. Although tolerated well, an association with new-onset diabetes has recently been suggested. One trial suggested a 27% increased risk of diabetes with rosuvastatin whereas...